Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Identification of lysosomotropic compounds based on the distribution and size of lysosomes.

Authors:
Incheol Seo Bijay Kumar Jha Jeong-Geun Lim Seong-Il Suh Min-Ho Suh Won-Ki Baek

Biochem Biophys Res Commun 2014 Jul 27;450(1):189-94. Epub 2014 May 27.

Department of Microbiology, School of Medicine, Keimyung University, Daegu, Republic of Korea; Institute for Cancer Research, School of Medicine, Keimyung University, Daegu, Republic of Korea. Electronic address:

Lysosomal accumulation of drugs with their specific physicochemical properties is of key importance to drug distribution in the body. Several attempts have been made to treat various human diseases by employing the accumulation of lysosomal drugs, and many methods to identify lysosomal accumulation of drugs have been proposed. Among those, the use of high-content screening has increased tremendously because of improved efficiency and accuracy as well as the development of automatic image acquisition and analytical techniques. Conventional methods to identify lysosomal accumulation of drugs by evaluating changes in the lysosomal area are unable to maximize the advantages of phenotypic high-content screening. Lysosomal distribution and the size of lysosomes are affected by lysosomal accumulating drugs. Therefore, we present image acquisition conditions and analytical methods to utilize lysosomal distribution and size as parameters for identifying lysosomal accumulating drugs. These two parameters will help to improve the reliability of the screening methods for identifying lysosomal accumulation of drugs by maximizing usage of information from image-based screening.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2014.05.091DOI Listing
July 2014

Publication Analysis

Top Keywords

lysosomal accumulation
16
accumulation drugs
16
distribution size
12
lysosomal
10
size lysosomes
8
lysosomes lysosomal
8
accumulating drugs
8
lysosomal accumulating
8
methods identify
8
identify lysosomal
8
high-content screening
8
identifying lysosomal
8
lysosomal distribution
8
image acquisition
8
drugs
7
accumulation
5
improved efficiency
4
acquisition conditions
4
proposed high-content
4
drugs parameters
4

Similar Publications

Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.

Authors:
Rutiane Ullmann Thoen Larisse Longo Santiago Cassales Neto Mário Reis Álvares-da-Silva

Clin Res Hepatol Gastroenterol 2021 Mar 1;45(6):101638. Epub 2021 Mar 1.

Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Experimental Laboratory of Hepatology and Gastroenterology, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Division of Gastroenterology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Introduction And Objective: Metabolic associated fatty liver disease (MAFLD), characterized by intra-hepatic fat accumulation, will soon be the leading cause of end-stage liver disease. Lysosomal Acid Lipase (LAL) is a key enzyme in lipid metabolism. We investigated its activity in patients with biopsy-proven MAFLD. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?

Authors:
Frédéric Checler Elissa Afram Raphaëlle Pardossi-Piquard Inger Lauritzen

J Biol Chem 2021 Mar 1:100489. Epub 2021 Mar 1.

Université de Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire UMR7275 CNRS, Laboratoire d'Excellence Distalz, Sophia-Antipolis, 06560 Valbonne, France.

Genetic, biochemical and anatomical grounds led to the proposal of the amyloid cascade hypothesis centered on the accumulation of amyloid beta peptides (Aβ) to explain Alzheimer's disease (AD) etiology. In this context a bulk of efforts have aimed at developing therapeutic strategies seeking to reduce Aβ levels, either by blocking its production (γ- and β-secretase inhibitors) or by neutralizing it once formed (Aβ-directed immunotherapies). However, so far the vast majority, if not all, clinical trials based on these strategies have failed, since they have not been able to restore cognitive function in AD patients, and even in many cases, they have worsened the clinical picture. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Altered Macrophage Function Associated with Crystalline Lung Inflammation in Acid Sphingomyelinase Deficiency.

Authors:
Joanna M Poczobutt Andrew M Mikosz Christophe Poirier Erica L Beatman Karina A Serban Fabienne Gally Danting Cao Alexandra L McCubbrey Christina F Cornell Kelly S Schweitzer Evgeny V Berdyshev Irina A Bronova François Paris Irina Petrache

Am J Respir Cell Mol Biol 2021 Mar 4. Epub 2021 Mar 4.

National Jewish Health, 2930, Medicine, Denver, Colorado, United States.

Deficiency of acid sphingomyelinase (ASM) causes the lysosomal storage Niemann-Pick disease (NPD). NPD type B patients may develop progressive interstitial lung disease with frequent respiratory infections. Although several investigations using the ASM deficient (ASMKO) mouse NPD model revealed inflammation and foamy macrophages, there is little insight into the pathogenesis of NPD-associated lung disease. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Non-invasive intradermal imaging of cystine crystals in cystinosis.

Authors:
Marya Bengali Spencer Goodman Xiaoying Sun Magdalene A Dohil Ranjan Dohil Robert Newbury Tatiana Lobry Laura Hernandez Corinne Antignac Sonia Jain Stephanie Cherqui

PLoS One 2021 4;16(3):e0247846. Epub 2021 Mar 4.

Division of Genetics, Department of Pediatrics, University of California, San Diego, La Jolla, California, United States of America.

Importance: Development of noninvasive methodology to reproducibly measure tissue cystine crystal load to assess disease status and guide clinical care in cystinosis, an inherited lysosomal storage disorder characterized by widespread cystine crystal accumulation.

Objective: To develop an unbiased and semi-automated imaging methodology to quantify dermal cystine crystal accumulation in patients to correlate with disease status.

Design, Setting And Participants: 101 participants, 70 patients and 31 healthy controls, were enrolled at the University of California, San Diego, Cystinosis Clinics, Rady Children's Hospital, San Diego and at the annual Cystinosis Research Foundation family conference for an ongoing prospective longitudinal cohort study of cystinosis patients with potential yearly follow-up. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Defective lysosomal storage in Fabry Disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cells.

Authors:
Anke Schumann Kristin Schaller Véronique Belche Markus Cybulla Sarah C Grünert Nicolai Moers Jörn Oliver Sass Andres Kaech Luciana Hannibal Ute Spiekerkoetter

J Inherit Metab Dis 2021 Mar 4. Epub 2021 Mar 4.

Department of General Paediatrics, Adolescent Medicine and Neonatology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Fabry disease (FD) is an X-linked lysosomal storage disorder. Deficiency of the lysosomal enzyme alpha-galactosidase (GLA) leads to accumulation of potentially toxic globotriaosylceramide (Gb3) on a multisystem level. Cardiac and cerebrovascular abnormalities as well as progressive renal failure are severe, life-threatening long-term complications. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap